Market Place
Sourcing Support
Dewpoint & ConcertAI Announce Translational Oncology Partnership
12 Dec 2024 //
GLOBENEWSWIRE
Dewpoint & Mitsubishi Tanabe Collaborate on ALS Treatment
04 Dec 2024 //
GLOBENEWSWIRE
Dewpoint collects new pharma partner for preclinical ALS program
04 Dec 2024 //
FIERCE BIOTECH
Dewpoint Nominates DPTX3186 for Wnt-Driven Cancer Treatment
28 Oct 2024 //
#N/A
Bayer and Dewpoint sign Licensing Agreement for Heart Disease Program
25 Oct 2024 //
GLOBENEWSWIRE
Dewpoint Therapeutics Awarded Target ALS Grant for c-mods Development in ALS
26 Aug 2024 //
GLOBENEWSWIRE
Dewpoint Therapeutics Awarded Second Target ALS Grant For C-Mods Development
26 Aug 2024 //
GLOBENEWSWIRE
Dewpoint trims headcount, pipeline to take condensates to clinic
17 Jan 2024 //
FIERCE BIOTECH
Dewpoint Therapeutics Awarded Target ALS Grant for Development of C-mods for ALS
16 Jan 2024 //
GLOBENEWSWIRE
Dewpoint Filed Multiple Patent Applications for the Treatment of ALS
07 Jan 2024 //
GLOBENEWSWIRE
Dewpoint Therapeutics Enters Strategic Partnership with Evotec
07 Nov 2023 //
GLOBENEWSWIRE
Dewpoint Therapeutics Partners with Chemify to Apply Groundbreaking Chemistry AI
12 Sep 2023 //
PR NEWSWIRE
Novo Nordisk inks $745M biobucks pact with Dewpoint
23 Mar 2023 //
FIERCE BIOTECH
Dewpoint partners with Novo to explore the field of biomolecular condensates
22 Mar 2023 //
PR NEWSWIRE
Dewpoint Granted Condensates Platform Technology Patent by US Patent Office
14 Nov 2022 //
PRNEWSWIRE
How Might Biomolecular Condensates Revolutionize Drug Discovery?
17 Aug 2022 //
PRNEWSWIRE
Dewpoint Appoints Michael Wagner
16 Jun 2021 //
PRNEWSWIRE
Pfizer taps Dewpoint Therapeutics in $239M dystrophy drug deal
06 Jan 2021 //
FIERCEBIOTECH
Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies
06 Jan 2021 //
PRNEWSWIRE
Dewpoint, fresh off a $77M round, snags a CEO
15 Oct 2020 //
FIERCE BIOTECH
Dewpoint Therapeutics nets $77M in series B round
29 Sep 2020 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.